MOSCOW, January 2. /TASS/. Head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said that Russia is ready to fully transfer technology for production of the Sputnik V coronavirus vaccine to Ukraine.
“Of course, we are ready to fully transfer our technologies for the production of [the Sputnik V vaccine] in Ukraine,” he said in an interview with Rossiya 1 TV channel.
Dmitriev added that the Russian Direct Investment Fund is ready to start joint trials of a combination of vaccines against coronavirus from AstraZeneca and Sputnik V in Ukraine. “We <…> are even ready to begin clinical trials of the joint AstraZeneca – Sputnik V vaccine in Ukraine. We are ready to cooperate with Ukraine in every possible way,” he added.
RDIF is ready to start joint trials of a combination of vaccines against coronavirus from AstraZeneca and Sputnik V in Ukraine, Dmitriev said. “We <…> are even ready to begin clinical trials of the joint AstraZeneca – Sputnik V vaccine in Ukraine. We are ready to cooperate with Ukraine in every possible way,” he added.
Earlier, the Gamaleya Research Institute of Epidemiology and Microbiology, RDIF, R-Pharm, and AstraZeneca signed a memorandum of cooperation in the development of vaccine against coronavirus. According to the director of the Gamaleya Institute Alexander Gintsburg, the combination of the Russian Sputnik V vaccine and the drug from pharmaceutical company AstraZeneca will provide protection against coronavirus infection for two years.
